Chad H. Martin - May 2, 2022 Form 4 Insider Report for MeridianLink, Inc. (MLNK)

Role: Chief Financial Officer
Signature: /s/ Kayla Dailey, as Attorney-in-Fact
Stock symbol: MLNK
Transactions as of: May 2, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/4/2022, 05:43 PM
Previous filing: Aug 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLNK	Common Stock, par value $0.001	Award	$0	+110K	+20.73%	$0.00	642K	May 2, 2022	Direct	F1
holding	MLNK	Common Stock, par value $0.001						89.9K	May 2, 2022	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MLNK	Stock Option (option to buy)	Award	$0	+81.5K		$0.00	81.5K	May 2, 2022	Common Stock, par value $0.001	81.5K	$16.61	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were granted pursuant to a restricted stock unit award ("RSU"). 25% of the shares subject to the RSU award shall vest on May 2, 2023, and the remaining 75% of the shares subject to the RSU award shall vest in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following May 2, 2023, subject to the reporting person's continued service relationship with the Company through each such vesting date.
F2	The shares are held directly by the Martin Family Trust dated March 9, 2010. The reporting person and his spouse are the co-trustees of the Martin Family Trust dated March 9, 2010 and share sole voting and dispositive power with respect to all securities held by such entity, and the reporting person may be deemed to be the beneficial owner of the securities held by the Martin Family Trust dated March 9, 2010.
F3	25% of the shares underlying the option shall vest and become exercisable on May 2, 2023, and the remaining 75% of the shares underlying the option shall vest and become exercisable in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following May 2, 2023, subject to the reporting person's continued service relationship with the Company through each applicable vesting date.